Keyphrases
Estrogen Receptor
100%
CD55
100%
Estrogen Receptor Gene
100%
Cyclin D1 (CCND1)
100%
Squamous Carcinoma Cells
100%
Cutaneous Squamous Cell Carcinoma (cSCC)
100%
GPR30
63%
A431 Cells
36%
Tumor Marker
27%
Estrogen
18%
Estrogen Receptor Agonists
18%
G Protein-coupled Receptor
9%
Receptor-interacting Protein Kinase 1 (RIPK1)
9%
Oral Contraceptives
9%
Receptor Activation
9%
Protein Expression
9%
Quantitative PCR
9%
MRNA Level
9%
Protein Level
9%
Western Blotting
9%
Confocal Microscopy
9%
MRNA Expression
9%
Differentially Expressed
9%
Subtype-specific
9%
Protective Behavior
9%
A431
9%
Malignant Transformation
9%
Population-based Study
9%
Specific Expression
9%
Clinical Population
9%
Gender Bias
9%
Worse Prognosis
9%
Nuclear Expression
9%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Receptor Subtype
100%
Cyclin D1
100%
Decay Accelerating Factor
100%
Skin Carcinoma
100%
Tumor Marker
16%
Receptor Agonist
11%
Messenger RNA
11%
G Protein Coupled Receptor
5%
Clinical Study
5%
Western Blot
5%
Confocal Microscopy
5%
Population Study
5%
Oral Contraceptive
5%
Malignant Transformation
5%
Cytoplasmic Receptor
5%
Immunology and Microbiology
Decay-Accelerating Factor
100%
Agonist
100%
Squamous Cell Carcinoma Cell
100%
Cyclin D1
100%
Squamous Cell
71%
Protein Expression
14%
Western Blot
14%
Downregulation
14%
Quantitative Reverse Transcription Polymerase Chain Reaction
14%
Animal Experiment
14%
Population Research
14%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
100%
Agonist
100%
Decay-Accelerating Factor
100%
Cyclin D1
100%
A431 Cells
22%
Tumor Marker
16%
Receptor Agonists
11%
Messenger RNA
11%
G Protein Coupled Receptor
5%
Downregulation
5%
Protein Expression
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Population Research
5%
Confocal Microscopy
5%
Malignant Transformation
5%
Gender Bias
5%
Clinical Study
5%
Animal Experiment
5%
Western Blotting
5%